The global Amniotic Membrane Market size is expected to reach USD 5.81 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a CAGR of 12.6% during the forecast period. Rise in trauma, burn cases and resulting surgeries along with increasing awareness regarding the benefits of these products are boosting the market growth. Rising number of cosmetic surgeries performed is also anticipated to drive the market during the forecast period. Amniotic membrane is also used in the treatment of a large number of ocular surface diseases as it protects surfaces from microbial colonization preventing the risk of infections.
Moreover,
presence of growth factors including basic Fibroblast Growth Factor (bFGF),
Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Vascular
Endothelial Growth Factor (VEGF), Nerve Growth Factor (NGF), and Keratinocyte
Growth Factor (KGF) in amniotic membranes promote wound healing, accelerating
its adoption globally. Thus, its benefits, such as anti-inflammatory properties,
reduced fibrosis and scarring at the site of surgery, pain reduction, and wound
healing properties, are also fueling the demand. These products are thus most
commonly used in surgeries, treatment of venous, pressure, and diabetic foot
ulcers, ophthalmology, and in the management of chronic wounds.
The
American Association of Tissue Banks is a non-profit organization that
regulates tissue donation in U.S. Presence of such tissue banks ensures zero
disease transmission, which, in turn, propels market growth. Furthermore, a
number of institutes are trying to introduce novel areas of applications for
these products by focusing on the research activities in stem cell and
regenerative medicines. This factor is also likely to support market expansion.
The use of cryopreserved amniotic membrane is largely seen in hospitals,
Ambulatory Surgical Centers (ASCs), and specialty clinics. Lyophylization of
the tissue post donation preserves the histological and biological activity of
the tissue facilitating faster wound recovery.
Request
a sample copy or view summary of this report@ https://www.grandviewresearch.com/industry-analysis/amniotic-membrane-market
Further key findings from the study suggest:
- Cryopreserved
is expected to be the dominant segment in future as it’s highly effective
and ensures preservation of histological and biological properties
- Surgical
wounds segment is projected to witness high growth due to increasing usage
of these products for surgical applications
- Specialty
clinics are anticipated to register the highest CAGR during the forecast
period due to increasing number of cosmetic and reconstructive surgeries
being performed
- North
America is a leading regional market owing to presence of a large number
of key companies and high incidence of chronic and infectious diseases
- The Asia
Pacific region is expected to record the highest CAGR during the forecast
period due to growing population and rising incidence of chronic diseases
and burn injuries
- Major
companies in the amniotic membrane market include Alliqua BioMedical Inc.;
Amnio Technology, Applied Biologics LLC; Human Regenerative Technologies
DermaSciences; Katena Products, MiMedx Group Inc.; and Skye Biologics,
Inc.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment